Epstein-Barr virus (EBV) was labelled with aH-thymidine and purified about 1000-fold from the culture medium by ultracentrifugation on 5 to 30% dextran gradients. The presence of the virus was monitored by radioactivity and Epstein-Barr virus-determined nuclear antigen (EBNA) induction in sensitive indicator cells (Ramos). Peaks for both activities occurred in the 17 to 18 % dextran fractions. Unlabelled virus recovered in the peak fraction was labelled with 125I. Both thymidine and 12~I-labelled purified virus bound quantitatively to receptor-positive Burkitt lymphoma-derived cell lines but not to EBV-receptor-negative T-lymphocytederived cell lines. Thymidine-labelled virus that was allowed to bind to Raji cells was present in the interior of briefly trypsinized cells after 3 h incubation at 37 °C. The results provide a convenient method for detecting the EBV receptor by radioactively labelled virus.
2.8 separation t, 22-34 % sucrose 1.5 ND 400 1 : 2 1.3 1 • 400 0 2nd gradient f 17-18 % dextran 1.5 5 320 1 : 2 32.0 1:300 6.0 separation ~22-34% sucrose 1.5 ND 320 1:2 0-3 1 : 300 0 * The virus was prepared from 21 B95-8 cell growth medium as described. After clarifying 2 ml of concentrated virus, the preparation was split into two equal volumes and applied to dextran and sucrose gradients in parallel. Purified 125I-labelled virus was used as a marker. The radioactivity peaks were collected and tested for EBNA induction. 75% and 70% of the radioactivity applied was recovered in 1.5 ml of the peak fractions of dextran and sucrose first gradients, respectively. In the second gradients, 80% and 70% of the first gradient peak was recovered from the 1.5 ml dextran and sucrose peaks. Protein was assayed by the method of Lowry et al. (1951) .
Infectivity of the virus was assayed by its ability to induce EBNA (Reedman & Klein, 1973) in the EBV-negative American Burkitt lymphoma line, Ramos .
t Virus concentration was calculated from volume concentration and recovery of virus marker. :[: NO, Not determined. radioactivity peaks were pooled, diluted twofold in the gradient buffer, and layered on to a 10 to 30% dextran gradient. After centrifugation for 1 h at 22000 rev/min in an S W 2 7 . 1 rotor the gradient was fractionated and assayed as after the first ultracentrifugation. The peak fractions of E B N A induction and radioactivity were collected and utilized for the binding assays. The entire virus purification procedure was carried out at 4 ° C.
The B95-8 substrain of EBV was purified on dextran or sucrose gradients as described above. The radioactive peak coincided with the peak of EBNA-inducing capacity at 22 to 34% sucrose and 17 to 18% dextran. The fractions in these areas were collected and ultracentrifuged a second time, on 5 to 5 0 % sucrose or 10 to 3 0 % dextran continuous gradients. In the second gradient, more than 9 0 % of the counts were found as a single peak at the same concentrations of the gradient medium. E B N A induction was followed throughout the purification procedure on both sucrose and dextran (Table 1) . DNase treatment of the first-gradient virus did not affect the E B N A inducibility or radioactivity profiles of the second gradient. The appearance of the peaks in the 17 to 18 % dextran fractions is in agreement with electron microscope findings of intact virions in this region (Dolynuik et al., 19 76) . The results strongly indicate that the radioactivity in the peak fractions is associated with virus. Virus purified in dextran retained over 9 0 % of original infectivity, whereas the sucrose-purified preparations were less than 5 % viable as estimated previously (Adams, 1975) . Various concentrations of Percoll (Pharmacia) were also utilized as an ultracentrifugation medium, but none produced a sharp peak of radioactivity and/or EBNA-inducing activity. The broad peaks centred around a density of 1.028 g/ml (data not shown). We discontinued the use of this medium, due to the breadth of the peak.
When infectivity was followed throughout the purification procedure, the loss of EBNA-inducing capacity was insignificant. The virus preparations were able to retain their original infectivity after two gradients in spite of obvious loss of some virions during the purification steps. A probable explanation is that before purification, the viable virus particles were in competition with non-infectious viral and cell membrane components, inhibiting their binding to the receptor sites. The clarification step removed much of this blocking material as shown by the increased infectivity (Table 1) . Dextran gradient purification, while destroying some virus, is efficient in removing the remaining non-infective blocking material. The virus preparation purified in sucrose retained very little infectivity, probably due to virion destruction resulting from the reduced hydrophilicity of the sucrose (Adams, 1975) .
The radioactivity peak of the second gradient was used to assess the binding of labelled virus to EBV receptor-positive prototype, Burkitt lymphoma-derived, cell lines (Fig. 1) . Aliquots of purified, radiolabelled virus (2000 ct/min/15 ~1) were incubated with between 0.1 x 106 and 15 x 106 cells in 1 ml Dulbecco's balanced salt solution (BSS) containing 1% bovine serum albumin (BSA). After 30 min incubation the cell suspension was applied to the top of 1 ml 10% sucrose in BSS. This was then spun for 90 s at 9000 g and the pellet washed once with 1% BSA in BSS. The radioactivities of the pellet and supernatants were measured independently. For the binding assays the above incubation was performed at 4 °C, room temperature and 37 °C with identical results. Percentage virus binding at a certain cell amount was calculated as follows:
Percentage bindingCell-associated counts -cell-free tube-associated counts
Applied counts -cell-free tube-associated counts × 100
As shown in Fig. 1 (a) , approx. 90% of the applied counts of the in vivo labelled virus were adsorbed by Raji cells (Klein et al., 1978; Epstein et aL, 1966) , with Daudi cells (Klein et al., 1978) binding slightly less, in agreement with findings from the adsorption bioassay (Sairenji & Hinuma, 1973) . Only 3 % of the gross counts were adsorbed by EBV receptor-negative Short communications human and murine T-cell-derived lines, 1301 (Jondal et al., 1976) and YAC (Klein et al., 1979) .
Virus collected from the first gradient was treated with 1 unit bovine pancreas deoxyribonuclease I (Sigma) for 10 min at room temperature, to remove any nonencapsulated DNA. The treated virus was recovered from the second gradient and tested for binding ability (Fig. 1 a) . The DNase treatment did not affect the binding results. These results indicate that approx. 90% of the counts in the preparation were associated with virus that bound selectively to EBV receptor-positive cells.
Aliquots of thymidine-labelled virus from the second gradient were treated by adding an equal volume of 0.25% trypsin (Sigma) for 5 min or 25 units of Vibrio cholera neuraminidase (BDH) for 30 min at 37 °C in BSS. The treated virus was diluted fourfold with gradient buffer, pelleted by centrifugation at 15000 g, and tested for binding. The viral binding capacity to Raji cells was not reduced by neuraminidase, but trypsin treatment decreased virus binding by greater than 90% (Fig. 1 a) .
The fate of the virus bound to Raji cells was checked. Fifty-eight % of the counts bound at 1 h were still present after 27 h of incubation in the absence of virus. After 2 h incubation in the absence of virus, the cells were briefly trypsinized to remove cell surface-attached virus which failed to penetrate the cells. Forty-eight % of the counts bound to the cells were associated with the trypsinized cells (Fig. 1 a) . Half of the virus capable of binding is therefore assumed to enter the cell's interior.
Purified virus was iodinated in vitro by the chloramine-T method and purified on repeated dextran gradients. The virus, not significantly destroyed by radio-iodination and centrifugation three times, appeared in a single peak on 17 to 18% dextran which bound quantitatively to receptor-positive cells, Raji and Daudi, but not to receptor-negative cells, 1301 and YAC (Fig. l b) . As shown in the figure, the virus binding was blocked by co-incubation with a 10-fold excess of non-labelled virus. Selective binding of 40% of the gross count is fully sufficient to demonstrate the presence of receptors, since only a small amount of radioactivity (<5 %) bound to the negative controls. The results are in accord with those obtained by the thymidine-labelled virus binding and earlier method of Sairenji & Hinuma (1973) . The cells were treated with trypsin or neuraminidase and subsequently tested for ability to adsorb virus. Trypsin treatment rendered the cells incapable of adsorbing virus, whereas exposure to neuraminidase did not affect this property. The results show that purified thymidine-labelled and iodinated EBV binds quantitatively to receptor-positive but not to receptor-negative cells. In earlier studies; the bioassay of infectious virus remaining after adsorption by a known number of cells was utilized to assess receptors. This assay, developed by Sairenji & Hinuma (1973) , has given useful information but is only partially quantitative at best. It is laborious, with many steps, and is incapable of yielding information about the intracellular fate of the virus. Direct binding of thymidine-labelled virus has considerable advantages for quantitative measurement of virus binding and the further study of virus-cell interactions. However, thymidine labelling of the virus requires a large amount-of expensive isotope and scintillation counting. 125I-labelled virus was also capable of selectively binding to EBV receptor-positive cells, even though the label is not only associated with the virus but also with non-viral proteins (N. Koide et al., unpublished observations) . The advantage of this method lies in the fact that the virus can be labelled more intensely and therefore less virus is required for the receptor assay. For a quick microassay of EBV receptors, 125I-labelled virus is preferred.
